Abbvie Inc. vs Tenet Healthcare Corporation New
ABBV vs THC — side-by-side comparison from reported financials. ABBV leads 4, THC leads 6 of 10 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Tenet Healthcare Corporation New
THC · Healthcare
$264.31+1.44%Mixed
| Metric | ABBV | THC |
|---|---|---|
| Price | $276.43 | $264.31 |
| Market cap | $488B | $21.3B |
| Revenue (TTM) | $64.4B | $21.8B |
| Revenue growth | +1.8% | +3.6% |
| Net margin | 9.8% | 10.3% |
| Free cash flow | $18.2B | $3.02B |
| Net cash (debt) | ($56.2B) | ($10.3B) |
| 1-year price return | +19.8% | +35.6% |
| P/E | 77.4 | 9.5 |
| P/E vs own history (cheap-side %) | 23% | 50% |
| Dividend yield | 2.45% | — |
| Return on equity | 96% | 51% |
| Altman Z-score | 2.33 | 1.51 |
| CV checks passed | 9 of 11 | 9 of 11 |
| Employees | 57,000 | 99,000 |
Full résumé-style profiles: ABBV CV · THC CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.